Migraine sufferers test new relief pill in everyday life
NCT ID NCT05709106
Summary
This study aimed to see how well and how safely the medication Rimegepant works for treating migraine attacks in real-world settings. It followed 173 adults with migraines for a year as they used the medication when needed. Researchers tracked how quickly pain eased, how often migraines occurred, and whether people could return to normal activities.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruijin-Hainan Hospital Shanghai Jiao Tong University School of Medicine
Boao, Hainan, 571434, China
Conditions
Explore the condition pages connected to this study.